INLYTA 1 mg/1 (Axitinib TABLET, FILM COATED) 1 mg/1

INLYTA 1 mg tablets are a pharmaceutical product used for specific medical conditions. This oral medication is designed to support targeted therapy, offering a convenient film-coated tablet form for consistent dosing.

Strength

1 mg/1

Pack Size

180 TABLET, FILM COATED in 1 BOTTLE (0069-0145-01)

Manufacturer / TM Owner

Pfizer Laboratories Div Pfizer Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

INLYTA 1 mg tablets are primarily used in the management of certain types of cancer. This medication is often prescribed as part of a broader treatment plan to help control the progression of the disease. Patients and healthcare providers may explore what INLYTA is used for to understand its role in targeted therapy.

Side Effects

Common effects of INLYTA 1 mg tablets may include fatigue, diarrhea, and high blood pressure. Some users might experience nausea or decreased appetite. It's important to monitor these effects and discuss any concerns with a healthcare professional.

Precautions & Warnings

INLYTA 1 mg tablets should be handled with care, following the prescribed dosage and administration guidelines. Patients with a history of certain medical conditions should inform their healthcare provider before starting this medication. Proper storage and regular monitoring are essential for safe use.

Avoid Interactions

INLYTA 1 mg tablets may interact with other medications, including those metabolized by the liver's CYP enzymes. Alcohol and certain over-the-counter drugs could also affect its efficacy. Always consult a healthcare provider to avoid potential interactions.

References

Frequently Asked Questions

INLYTA is used in the treatment of specific types of cancer as part of a targeted therapy plan.

INLYTA tablets are taken orally, typically following the dosage instructions provided by a healthcare professional.

Common side effects may include fatigue, diarrhea, and high blood pressure. Always consult a healthcare provider for personalized advice.

INLYTA may interact with other medications, so it's important to discuss all current medications with a healthcare provider.

INLYTA should be stored at room temperature, away from moisture and heat, following the storage guidelines provided.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.